Companies / Zelluna
Zelluna
Norway
Zelluna is developing a unique and proprietary TCR-NK cell therapy platform to treat solid cancers
Zelluna, based in Norway, has 2 investors on file, among them Birk Venture and Radforsk. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor | |
| Portfolio page | Venture capital |
More from Birk Venture
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (71%), Industrial & Manufacturing (14%), E-commerce & Marketplaces (14%).
More from Radforsk
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Zelluna and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Birk Venture adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/zelluna.com/investors
# also
GET /v1/companies/zelluna.com
GET /v1/companies/zelluna.com/news